Aptevo Therapeutics Inc. Increase (Decrease) in Other Accounts Payable and Accrued Liabilities
Aptevo Therapeutics Inc. (APVO) reported Increase (Decrease) in Other Accounts Payable and Accrued Liabilities of -$1.51 million for the 6-month period ending 2018-06-30, per its 10-Q filed 2018-08-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities · last filed 2018-08-09
- Aptevo Therapeutics Inc. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2018-06-30 was $1.86M.
- Aptevo Therapeutics Inc. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2018-03-31 was -$3.37M.
- Aptevo Therapeutics Inc. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2017-12-31 was $2.14M, a 41.22% decline year-over-year.
- Aptevo Therapeutics Inc. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2017-09-30 was $3.20M.
- Aptevo Therapeutics Inc. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2017 was $195.00K, a 92.13% decline from fiscal 2016.
- Aptevo Therapeutics Inc. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2016 was $2.48M.
- Aptevo Therapeutics Inc. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2015 was -$2.38M.
| Period end | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 3 month as first filed | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|---|---|
| 2018-06-30 | $1.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$1.51M 10-Q · filed 2018-08-09 | $626.00K derived: sum of 3 quarters · filed 2018-08-09 | $3.82M derived: sum of 4 quarters · filed 2018-08-09 | ||
| 2018-03-31 | -$3.37M 10-Q · filed 2018-05-10 | -$1.24M derived: sum of 2 quarters · filed 2018-05-10 | $1.96M derived: sum of 3 quarters · filed 2018-05-10 | $1.74M derived: sum of 4 quarters · filed 2018-08-09 | ||
| 2017-12-31 | $2.14M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | $5.33M derived: sum of 2 quarters · filed 2018-03-13 | $5.11M derived: sum of 3 quarters · filed 2018-08-09 | $195.00K 10-K · filed 2018-03-13 | ||
| 2017-09-30 | $3.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $2.98M derived: sum of 2 quarters · filed 2018-08-09 | -$1.94M 10-Q · filed 2017-11-13 | $1.69M derived: sum of 4 quarters · filed 2018-08-09 | ||
| 2017-06-30 | -$223.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$5.14M 10-Q · filed 2018-08-09 | -$5.72M 10-Q · filed 2017-08-10 | -$1.50M derived: sum of 3 quarters · filed 2018-08-09 | -$2.46M derived: sum of 4 quarters · filed 2018-08-09 | |
| 2017-03-31 | -$4.92M 10-Q · filed 2018-05-10 | -$4.18M 10-Q · filed 2017-05-12 | -$1.28M derived: sum of 2 quarters · filed 2018-05-10 | -$2.24M derived: sum of 3 quarters · filed 2018-05-10 | -$3.78M derived: sum of 4 quarters · filed 2018-05-10 | |
| 2016-12-31 | $3.63M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | $2.68M derived: sum of 2 quarters · filed 2018-03-13 | $1.13M derived: sum of 3 quarters · filed 2018-03-13 | $2.48M 10-K · filed 2018-03-13 | ||
| 2016-09-30 | -$957.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | -$2.50M derived: sum of 2 quarters · filed 2017-11-13 | -$1.16M 10-Q · filed 2017-11-13 | -$3.78M derived: sum of 4 quarters · filed 2017-11-13 | ||
| 2016-06-30 | -$1.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | -$198.00K 10-Q · filed 2017-08-10 | -$2.83M derived: sum of 3 quarters · filed 2017-08-10 | |||
| 2016-03-31 | $1.35M 10-Q · filed 2017-05-12 | -$1.28M derived: sum of 2 quarters · filed 2017-05-12 | ||||
| 2015-12-31 | -$2.63M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | -$2.38M 10-K · filed 2017-03-31 | ||||
| 2015-09-30 | $244.00K 10-Q · filed 2016-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |